1 |
Wu J, Power H, Miranda-saksena M, Valtchev P, Schindeler A, Cunningham AL, Dehghani F. Identifying HSV-1 Inhibitors from Natural Compounds via Virtual Screening Targeting Surface Glycoprotein D. Pharmaceuticals 2022;15:361. [DOI: 10.3390/ph15030361] [Reference Citation Analysis]
|
2 |
Bisht D, Rashid M, Arya RKK, Kumar D, Chaudhary SK, Rana VS, Sethiya NK. Revisiting liquorice (Glycyrrhiza glabra L.) as anti-inflammatory, antivirals and immunomodulators: Potential pharmacological applications with mechanistic insight. Phytomedicine Plus 2022;2:100206. [DOI: 10.1016/j.phyplu.2021.100206] [Reference Citation Analysis]
|
3 |
Gomaa AA, Mohamed HS, Abd-Ellatief RB, Gomaa MA, Hammam DS. Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial. Inflammopharmacology 2022. [PMID: 35233748 DOI: 10.1007/s10787-022-00939-7] [Reference Citation Analysis]
|
4 |
Ruchawapol C, Yuan M, Wang SM, Fu WW, Xu HX. Natural Products and Their Derivatives against Human Herpesvirus Infection. Molecules 2021;26:6290. [PMID: 34684870 DOI: 10.3390/molecules26206290] [Reference Citation Analysis]
|
5 |
Yang J, Yan H, Liu Y, Da L, Xiao Q, Xu W, Su Z. GURFAP: A Platform for Gene Function Analysis in Glycyrrhiza Uralensis. Front Genet 2022;13:823966. [DOI: 10.3389/fgene.2022.823966] [Reference Citation Analysis]
|
6 |
Zamzami MA. Molecular docking, molecular dynamics simulation and MM-GBSA studies of the activity of glycyrrhizin relevant substructures on SARS-CoV-2 RNA-dependent-RNA polymerase. J Biomol Struct Dyn 2022;:1-13. [PMID: 35037842 DOI: 10.1080/07391102.2021.2025147] [Reference Citation Analysis]
|